SCHEMBL1109080

SCHEMBL1109080

FC1CCN(Cl)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12846927 0.80
SCHEMBL18964649 0.80
SCHEMBL2290316 0.71
SCHEMBL10210478 0.69
SCHEMBL9830002 0.69
SCHEMBL14669194 0.67
SCHEMBL1470777 0.66
SCHEMBL1414467 0.65
SCHEMBL12070427 0.64
SCHEMBL220016 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9580442-B2 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors KARUS THERAPEUTICS LIMITED (GB) 2017-02-28 US disclosed
US-20160368904-A1 SUBSTITUTED BENZOFURANYL AND BENZOXAZOLYL COMPOUNDS AND USES THEREOF Karyopharm Therapeutics Inc. 2016-12-22 US disclosed
US-20160130282-A1 MERCAPTOAMIDINE DERIVATIVES AND METHODS OF USE ABBVIE INC. 2016-05-12 US disclosed
US-20160108057-A1 TRICYCLIC HETEROCYCLIC COMPOUNDS AS PHOSPHOINOSITIDE 3-KINASE INHIBITORS CONVALIFE (SHANGHAI) CO. LIMITED (CN) 2016-04-21 US disclosed
US-9200007-B2 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors KARUS THERAPEUTICS LIMITED (GB) 2015-12-01 US disclosed
US-9181275-B2 Mercaptoamidine derivatives and methods of use ABBVIE INC. (US) 2015-11-10 US disclosed
US-8580968-B2 Benzothiazole and benzooxazole derivatives and methods of use ABBVIE INC. (US) 2013-11-12 US disclosed
EP-2386556-B1 Benzothiazole cyclobutyl amine derivatives and their use as histamine-3 receptors ligands ABBVIE INC (US) 2013-10-23 EP disclosed
US-20130040940-A1 MERCAPTOAMIDINE DERIVATIVES AND METHODS OF USE ABBVIE INC. (US) 2013-02-14 US disclosed
US-20120178737-A1 Tricyclic Heterocyclic Compounds as Phosphoinositide 3-Kinase Inhibitors CONVALIFE (SHANGHAI) CO. LIMITED (CN) 2012-07-12 US disclosed
US-8153813-B2 Benzothiazole and benzooxazole derivatives and methods of use ABBOTT LABORATORIES (US) 2012-04-10 US disclosed
EP-2386556-A1 Benzothiazole cyclobutyl amine derivatives and their use as histamine-3 receptors ligands Abbott Laboratories (US) 2011-11-16 EP disclosed
WO-2011119565-A1 IMAGING AGENTS FOR DETECTING NEUROLOGICAL DISORDERS SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2011-09-29 WO disclosed
US-20110207704-A1 Novel Oxadiazole Compounds ABBOTT LABORATORIES (US) 2011-08-25 US disclosed
US-20110182812-A1 Imaging Agents for Detecting Neurological Disorders SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2011-07-28 US disclosed
US-20090326222-A1 BENZOTHIAZOLE CYCLOBUTYL AMINE DERIVATIVES ABBOTT LABORATORIES (US) 2009-12-31 US disclosed
US-7576110-B2 Benzothiazole cyclobutyl amine derivatives ABBOTT LABORATORIES (US) 2009-08-18 US disclosed
US-20090163464-A1 BENZOTHIAZOLE AND BENZOOXAZOLE DERIVATIVES AND METHODS OF USE ABBOTT LABORATORIES (US) 2009-06-25 US disclosed
WO-2007038074-A1 BENZOTHIAZOLE CYCLOBUTYL AMINE DERIVATIVES AND THEIR USE AS HISTAMINE-3 RECEPTORS LIGANDS ABBOTT LABORATORIES (US) 2007-04-05 WO disclosed
US-20070066588-A1 Benzothiazole cyclobutyl amine derivatives ABBVIE INC. 2007-03-22 US disclosed